Search Results
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
Paolo Tarantino
Oct 12, 2023, 02:36 |
Blog
Paolo Tarantino: Truly grateful for the kind invitation and incredibly warm welcome by the Argentinian and Patagonian associations of clinical oncology.
Quoting Paolo Tarantino, Medical Oncologist and Research Fellow at Dana-Farber Cancer Institute, on X/Twitter: "Truly…
Oct 6, 2023, 15:32 |
Blog
Paolo Tarantino: Bright days ahead for ESMO journals!
Paolo Tarantino, Clinical Research Fellow at Dana-Farber Cancer Institute, shared on X/Twitter: “Congrats to the…
Oct 2, 2023, 22:37 |
Insight
Paolo Tarantino: Antibody drug conjugates (ADCs) are leading to relevant survival improvements for multiple types of cancer.
Paolo Tarantino, MD and researcher at the European Institute of Oncology and clinical research fellow…
Sep 21, 2023, 04:05 |
Drugs
Paolo Tarantino: The longest follow up to date of a metastatic trastuzumab trial.
Paolo Tarantino, a clinical research fellow at the Dana-Farber Cancer Institute, shared the following insight…
Sep 11, 2023, 18:26 |
Blog
Paolo Tarantino: Topics like ADCs bring all oncology disciplines closer, reminding us that we’re all together in the fight against cancer.
Quoting Paolo Tarantino, clinical research fellow at the Dana-Farber Cancer Institute, on Twitter: "Proud to…
Sep 10, 2023, 17:27 |
Insight
Paolo Tarantino: In our latest The Oncologist article led by Edoardo Crimini, we analyze geographical accessibility to NGS-informed trials in Italy
Paolo Tarantino, MD, Clinical research fellow at the Dana-Farber Cancer Institute, shared the following insight…
Sep 2, 2023, 00:32 |
Insight
Paolo Tarantino: The “5 S rules” can help memorize a simple framework to optimally manage ILD.
Paolo Tarantino, MD and researcher at the European Institute of Oncology and clinical research fellow…
Aug 29, 2023, 18:43 |
Blog
Paolo Tarantino: So many changes since last year... one thing, though - one corner, remained the same. Luckily.
Quoting Paolo Tarantino, Research Fellow at the Dana-Farber Cancer Institute, on X/Twitter: "So many changes…
Aug 24, 2023, 18:16 |
Blog
Paolo Tarantino: Retrospective study by Viale et al. on HER2-low breast cancer.
Quoting Paolo Tarantino, Research Fellow at the Dana-Farber Cancer Institute, on Twitter: ''Just out on…
Aug 23, 2023, 23:49 |
Blog
Paolo Tarantino: Interesting pan-cancer evaluation of HER2-low expression out on Annals of Oncology.
Paolo Tarantino, a Research Fellow at the Dana-Farber Cancer Institute, shared the following insights on…
12
13
14
15
16
All:
196
Posts:
131 - 140
Paolo Tarantino: Top 10 Breast Cancer abstracts from ESMO2024
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 2
Running for a Cure: The Legacy of Terry Fox's Marathon of Hope
How The Breast Cancer Research Foundation was founded
Can Skin Cancer be Prevented by a $0.50 Soap? Meet TIME’s Kid of the Year and His Invention
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube